Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease

作者: Kentaro Hirao , Gregory M. Pontone , Gwenn S. Smith

DOI: 10.1016/J.NEUBIOREV.2014.11.010

关键词:

摘要: Abstract Neuropsychiatric symptoms (NPS) are very common in neurodegenerative diseases and a major contributor to disability caregiver burden. There is accumulating evidence that NPS may be prodrome and/or “risk factor” of diseases. The medications used treat these younger patients not effective with disease have serious side effects. An understanding the neurobiology critical for development more intervention strategies. Targeting also implications prevention cognitive or motor decline. Molecular brain imaging represents bridge between basic clinical observations provides many opportunities translation from animal models human post-mortem studies vivo studies. Alzheimer's (AD) Parkinson's (PD) reviewed primary focus on positron emission tomography NPS. Future directions field molecular AD PD understand will discussed.

参考文章(244)
Oscar L Lopez, Saša Živković, Gwenn Smith, James T Becker, Carolyn Cidis Meltzer, Steven T DeKosky, None, Psychiatric Symptoms Associated With Cortical-Subcortical Dysfunction in Alzheimer's Disease The Journal of Neuropsychiatry and Clinical Neurosciences. ,vol. 13, pp. 56- 60 ,(2001) , 10.1176/JNP.13.1.56
Gwenn S Smith, Mony J de Leon, Ajax E George, Alan Kluger, Nora D Volkow, Thomas McRae, James Golomb, Steven H Ferris, Barry Reisberg, Joseph Ciaravino, Mary Ellen La Regina, Topography of Cross-sectional and Longitudinal Glucose Metabolic Deficits in Alzheimer's Disease: Pathophysiologic Implications JAMA Neurology. ,vol. 49, pp. 1142- 1150 ,(1992) , 10.1001/ARCHNEUR.1992.00530350056020
T. Witjas, E. Kaphan, J. P. Azulay, O. Blin, M. Ceccaldi, J. Pouget, M. Poncet, A. A. Cherif, Nonmotor fluctuations in Parkinson’s disease Frequent and disabling Neurology. ,vol. 59, pp. 408- 413 ,(2002) , 10.1212/WNL.59.3.408
Mónica Garcia-Alloza, Francisco J Gil-Bea, Mónica Diez-Ariza, CPL-H Chen, Paul T Francis, Berta Lasheras, María Javier Ramirez, Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease Neuropsychologia. ,vol. 43, pp. 442- 449 ,(2005) , 10.1016/J.NEUROPSYCHOLOGIA.2004.06.007
M. Petrou, N. I. Bohnen, M. L. T. M. Muller, R. A. Koeppe, R. L. Albin, K. A. Frey, Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia. Neurology. ,vol. 79, pp. 1161- 1167 ,(2012) , 10.1212/WNL.0B013E3182698D4A
Constantine G. Lyketsos, Jeannie-Marie E. Sheppard, Cynthia D. Steele, Susan Kopunek, Martin Steinberg, Alva S. Baker, Jason Brandt, Peter V. Rabins, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Sertraline in the Treatment of Depression Complicating Alzheimer’s Disease: Initial Results From the Depression in Alzheimer’s Disease Study American Journal of Psychiatry. ,vol. 157, pp. 1686- 1689 ,(2000) , 10.1176/APPI.AJP.157.10.1686
Cheryl L.P. Vigen, Wendy J. Mack, Richard S.E. Keefe, Mary Sano, David L. Sultzer, T. Scott Stroup, Karen S. Dagerman, John K. Hsiao, Barry D. Lebowitz, Constantine G. Lyketsos, Pierre N. Tariot, Ling Zheng, Lon S. Schneider, Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-AD American Journal of Psychiatry. ,vol. 168, pp. 831- 839 ,(2011) , 10.1176/APPI.AJP.2011.08121844
Kirk A. Frey, Robert A. Koeppe, Michael R. Kilbourn, Thierry M. Vander Borght, Roger L. Albin, Sid Gilman, David E. Kuhl, Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging Annals of Neurology. ,vol. 40, pp. 873- 884 ,(1996) , 10.1002/ANA.410400609
Lea T. Drye, Barbara K. Martin, Constantine E. Frangakis, Curtis L. Meinert, Jacobo E. Mintzer, Cynthia A. Munro, Anton P. Porsteinsson, Peter V. Rabins, Paul B. Rosenberg, Lon S. Schneider, Daniel Weintraub, Constantine G. Lyketsos, , Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)? International Journal of Geriatric Psychiatry. ,vol. 26, pp. 573- 583 ,(2011) , 10.1002/GPS.2565
Nagaendran Kandiah, Russell Chander, Angeline Zhang, Cheong Chin Yee, None, Cerebral white matter disease is independently associated with BPSD in Alzheimer's disease Journal of the Neurological Sciences. ,vol. 337, pp. 162- 166 ,(2014) , 10.1016/J.JNS.2013.11.042